ScinoPharm Taiwan Ltd (台灣神隆), which supplies pharmaceutical ingredients on a made-to-order basis, confirmed yesterday it would start offering ingredients to Vivus Inc this quarter for the sale of a new weight-loss pill in the US.
The Taiwanese firm’s confirmation came after the US-based Vivus announced overnight it had obtained approval from US regulators to sell the new drug, named Qsymia, and plans to start selling it by the end of the year.
“ScinoPharm announced today that its Tainan facility will provide commercial manufacturing of topiramate, the active pharmaceutical ingredient [API] for Vivus’ Qsymia, a new drug for the treatment of obesity approved by the United States Food and Drug Administration [FDA] on July 17, 2012,” the company said yesterday in a statement.
Qsymia is the second FDA-approved treatment for chronic weight management in adults in 13 years, after the US regulator on June 27 approved Arena Pharmaceutical’s anti-obesity pill Belviq.
For ScinoPharm, Qsymia is its fourth new drug approved by the US FDA, which it considers a more effective pill than Belviq.
Currently, ScinoPharm is working on more than 70 new projects with five entering Phase III clinical trials, according to the company.
Shares in ScinoPharm rose 1.23 percent to NT$57.7 in Taipei trading yesterday. The stock has risen 33.26 percent so far this year, compared with the TAIEX’s 1.08 percent increase over the same period. In US trading, Vivus surged 9.6 percent to US$29 on Wednesday.
ScinoPharm, located in the Tainan Science-based Industrial Park (台南科學園區), is the nation's largest API supplier to the global pharmaceutical and biotechnology companies. While serving the global generic industry, ScinoPharm also offers contract research and manufacturing services of existing and new drugs to companies around the world.
The company said its partnership with Vivus began with the supply of topiramate for the Qsymia clinical development program. ScinoPharm began commercial production of topiramate two years ago for the treatment of epilepsy and other nervous system disorders, it added.
With this approval for weight management, ScinoPharm president and chief executive Jo Shen (馬海怡) said in the statement that she expected the market potential for topiramate to increase substantially, without offering exact numbers.
Fubon Securities Investment Services Co (富邦投顧) analyst Heather Chang (張雅雯) said last month that Qsymia could become the world's most popular weight loss drug, after clinical studies showed that it can effectively assist in weight management without dangerous cardiovascular side effects.
"We forecast Qsymia can contribute between NT$100 million and NT$200 million to ScinoPharm's revenue this year and the sales of the drug will reach from NT$1 billion to NT$2 billion in five years," Chang said in a note on June 29.
ScinoPharm post NT$971 million in revenue in the first quarter of the year, down 13.9 percent from the fourth quarter of last year but up 22.2 percent from the same period of last year. Net income was NT$247 million in the first quarter, down 22.7 percent from the previous quarter but up 72 percent from a year earlier, with earnings per share (EPS) of NT$0.39.
Fubon forecast ScinoPharm's second-quarter revenue to show a sequential increase of 11 percent and an annual growth of 12 percent to NT$1.08 billion, while net income would grow 14 percent quarter-on-quarter and 10 percent year-on-year to NT$283 million, with NT$0.45 in EPS.
As the company's new production lines are due to come online later this year in Taiwan, coupled with contribution from the production of anti-depressant Viibryd and Galantamine for dementia, revenue is expected to rise 15.61 percent to NT$4.56 billion for the whole of this year and net income will grow 23 percent to NT$1.17 billion, with NT$1.86 in EPS, according to Fubon.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”